🇺🇸 FDA
Patent

US 12338438

Conjugated oligonucleotide compounds, methods of making and uses thereof

granted A61KA61K47/549

Quick answer

US patent 12338438 (Conjugated oligonucleotide compounds, methods of making and uses thereof) held by E-Therapeutics PLC expires Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
E-Therapeutics PLC
Grant date
Tue Jun 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K47/549